Can Fite Bio (CANF) Financial Statements

3 Followers

Can Fite Bio Financial Overview

Can Fite Bio's market cap is currently ₪20.85M. The company's EPS TTM is -19.324619874; its P/E ratio is -1.46; Can Fite Bio is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Mar 25	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 438.40K	$ 674.00K	$ 743.00K	$ 810.00K	$ 853.00K
Gross Profit	$ 412.42K	$ 674.00K	$ 743.00K	$ 810.00K	$ 853.00K
Operating Income	$ -10.77M	$ -8.13M	$ -8.20M	$ -10.10M	$ -12.84M
EBITDA	$ -10.74M	$ -8.12M	$ -8.18M	$ -10.08M	$ -12.83M
Net Income	$ -10.64M	$ -7.88M	$ -7.63M	$ -10.17M	$ -12.60M
Balance Sheet
Cash & Short-Term Investments	$ 8.54M	$ 7.89M	$ 8.92M	$ 7.98M	$ 19.14M
Total Assets	$ 9.52M	$ 9.12M	$ 9.99M	$ 9.28M	$ 20.25M
Total Debt	$ 71.01K	$ 104.00K	$ 40.00K	$ 62.00K	$ 124.00K
Net Debt	$ -5.46M	$ -4.72M	$ -4.24M	$ -2.92M	$ -4.27M
Total Liabilities	$ 3.92M	$ 3.68M	$ 3.75M	$ 4.81M	$ 5.87M
Stockholders' Equity	$ 5.59M	$ 5.44M	$ 6.24M	$ 4.47M	$ 14.38M
Cash Flow
Free Cash Flow	$ -9.69M	$ -7.64M	$ -8.44M	$ -10.81M	$ -9.87M
Operating Cash Flow	$ -9.69M	$ -7.64M	$ -8.44M	$ -10.80M	$ -9.86M
Investing Cash Flow	$ -2.16K	$ 1.50M	$ 498.00K	$ 9.50M	$ -14.51M
Financing Cash Flow	$ 10.44M	$ 6.71M	$ 9.14M	$ 0.00	$ 20.46M

Currency in USD

Can Fite Bio Earnings and Revenue History

Income Statement >

Can Fite Bio Debt to Assets

Balance Sheet >

Can Fite Bio Cash Flow

Cash Flow >

Can Fite Bio Forecast EPS vs Actual EPS

Earnings >